This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2014.
Company Filing History:
Years Active: 2011-2014
Title: Innovations by Hidekazu Ikeuchi
Introduction
Hidekazu Ikeuchi is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on anti-cancer oligodeoxynucleotides. With a total of 2 patents, Ikeuchi's inventions aim to improve treatment options for various types of tumors.
Latest Patents
Ikeuchi's latest patents focus on the use of suppressive oligodeoxynucleotides (ODNs) for preventing or delaying tumor formation. These patents disclose methods for reducing the risk of developing tumors, treating existing tumors, and preventing the conversion of benign lesions to malignant ones. The methods outlined include selecting a subject for treatment and administering a therapeutically effective amount of one or more suppressive ODNs. Additionally, the patents suggest that other agents may also be administered to enhance treatment efficacy.
Career Highlights
Hidekazu Ikeuchi is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on groundbreaking research that has the potential to impact cancer treatment significantly.
Collaborations
Ikeuchi collaborates with Dennis M Klinman, a fellow researcher in the field. Their combined expertise contributes to the advancement of cancer research and the development of innovative treatment methods.
Conclusion
Hidekazu Ikeuchi's contributions to cancer research through his patents on anti-cancer oligodeoxynucleotides highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in cancer treatment.